Lower Drug Prices Announced Under Medicare Negotiation Program

CMS today announced the agreed-upon lower prices for all 10 drugs selected for price negotiations under the Inflation Reduction Act (IRA). These drugs are considered some of the most expensive and frequently dispensed throughout the Medicare program. According to CMS, the negotiated prices will allow Medicare patients with conditions like heart disease, diabetes, and cancer to access their medications more cost-effectively. ARTICLE